TRPM2 and renal fibrosis: On the other hand, other studies have found that TRPM2 suppression (which reduces inflammation and renal fibrosis by blocking TGF-β1-regulated JNK activation) might be a possible therapeutic target in renal fibrosis and chronic kidney disease prevention [189].